Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2122265491', 'doi': 'https://doi.org/10.1136/ard.2003.009589', 'title': 'Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor blockers can make sense', 'display_name': 'Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor blockers can make sense', 'publication_year': 2003, 'publication_date': '2003-11-23', 'ids': {'openalex': 'https://openalex.org/W2122265491', 'doi': 'https://doi.org/10.1136/ard.2003.009589', 'mag': '2122265491', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/14644858', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/1754380'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ard.2003.009589', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1136/ard.2003.009589', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5012009272', 'display_name': 'Ronald van Vollenhoven', 'orcid': 'https://orcid.org/0000-0001-6438-8663'}, 'institutions': [{'id': 'https://openalex.org/I1335113835', 'display_name': 'Karolinska University Hospital', 'ror': 'https://ror.org/00m8d6786', 'country_code': 'SE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335113835']}], 'countries': ['SE'], 'is_corresponding': True, 'raw_author_name': 'R van Vollenhoven', 'raw_affiliation_strings': ['Karolinska Hospital, D2-1, 17176 Stockholm, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Karolinska Hospital, D2-1, 17176 Stockholm, Sweden', 'institution_ids': ['https://openalex.org/I1335113835']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5012009272'], 'corresponding_institution_ids': ['https://openalex.org/I1335113835'], 'apc_list': None, 'apc_paid': None, 'fwci': 7.737, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 229, 'citation_normalized_percentile': {'value': 0.88666, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '62', 'issue': '12', 'first_page': '1195', 'last_page': '1198'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.8145107}], 'concepts': [{'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.9676846}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.9606929}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9109303}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.8145107}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.621012}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.6101309}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.38612986}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.33947682}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012042', 'descriptor_name': 'Registries', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017211', 'descriptor_name': 'Treatment Failure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ard.2003.009589', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc1754380', 'pdf_url': 'https://europepmc.org/articles/pmc1754380?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754380', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/14644858', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ard.2003.009589', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.41, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 8, 'referenced_works': ['https://openalex.org/W2026254148', 'https://openalex.org/W2064446309', 'https://openalex.org/W2110177517', 'https://openalex.org/W2129841863', 'https://openalex.org/W2159106700', 'https://openalex.org/W2319957449', 'https://openalex.org/W2328587823', 'https://openalex.org/W2340084730'], 'related_works': ['https://openalex.org/W2460286564', 'https://openalex.org/W2419359170', 'https://openalex.org/W2345141018', 'https://openalex.org/W2341953096', 'https://openalex.org/W2060702171', 'https://openalex.org/W2058674147', 'https://openalex.org/W2038285281', 'https://openalex.org/W2015993259', 'https://openalex.org/W2003561232', 'https://openalex.org/W1947312590'], 'abstract_inverted_index': {'<b>Objective:</b>': [0], 'When': [1], 'one': [2, 232], 'TNFα': [3, 227], 'blocker': [4, 228], '(etanercept': [5], 'or': [6, 31], 'infliximab)': [7], 'has': [8, 235], 'failed,': [9], 'to': [10, 16, 64, 88, 133, 203], 'determine': [11], 'whether': [12], 'it': [13], 'makes': [14], 'sense': [15], 'treat': [17], 'patients': [18, 27, 48, 56, 125, 174, 198, 230], 'with': [19, 29, 74, 76, 147, 175, 181, 207], 'the': [20, 42, 90, 99, 104, 154, 225], 'other.': [21], '<b>Patients': [22], 'and': [23, 114, 161, 167], 'methods:</b>': [24], 'Since': [25], '1999': [26], 'treated': [28], 'etanercept': [30, 58, 109, 142, 168, 208], 'infliximab': [32, 117, 127, 151, 166, 182, 191, 201], 'have': [33], 'been': [34], 'systematically': [35], 'followed': [36], 'up': [37], 'at': [38, 210], 'our': [39], 'institution': [40], 'in': [41, 156, 169, 229], 'STURE': [43], 'database.': [44], 'We': [45], 'identified': [46], '31': [47], 'who': [49, 199], 'had': [50, 70], 'received': [51, 57, 126], 'both': [52], 'agents.': [53], '<b>Results:</b>': [54], 'Eighteen': [55], 'first;': [59, 128], 'discontinuation': [60, 129], 'was': [61, 94, 111, 130, 143, 158], 'mostly': [62], 'due': [63, 132], 'lack': [65], 'of': [66, 83, 190, 224], 'efficacy.': [67, 214], 'DAS28': [68, 81, 93, 138, 157], 'values': [69], 'improved': [71], 'only': [72], 'slightly': [73], 'etanercept,': [75, 179], 'a': [77, 188, 222], 'mean': [78, 91, 105], '(SEM)': [79], 'best': [80, 92, 106, 137], 'value': [82, 139], '4.8': [84], '(0.6).': [85], 'After': [86], 'switching': [87], 'infliximab,': [89], '3.6': [95, 144], '(0.6)—significantly': [96], 'better': [97, 184], 'than': [98], 'previous': [100], 'result': [101], '(p<0.05).': [102], 'Similarly,': [103], 'ACR-N': [107, 162], 'during': [108, 115, 141], 'treatment': [110, 118, 180, 206], '17.2': [112], '(6.65)': [113], 'subsequent': [116], '40.4': [119], '(10.6)': [120], '(p': [121], '=': [122], '0.08).': [123], 'Thirteen': [124], 'mainly': [131], 'adverse': [134, 204], 'events.': [135], 'The': [136], 'achieved': [140], '(0.4)': [145, 149], 'compared': [146], '4.1': [148], 'for': [150, 165, 194, 221], '(p<0.05),': [152], 'but': [153], 'change': [155], 'not': [159], 'different': [160], 'were': [163], 'similar': [164, 212], 'this': [170], 'group.': [171], '<b>Conclusion:</b>': [172], 'For': [173, 197], 'insufficient': [176], 'efficacy': [177], 'from': [178], 'provided': [183], 'results,': [185], 'suggesting': [186], 'that': [187], 'trial': [189, 223], 'is': [192], 'reasonable': [193], 'such': [195, 233], 'patients.': [196], 'discontinued': [200], 'owing': [202], 'events,': [205], 'gave': [209], 'least': [211], 'clinical': [213], 'Taken': [215], 'together,': [216], 'these': [217], 'data': [218], 'provide': [219], 'support': [220], 'reciprocal': [226], 'when': [231], 'agent': [234], 'failed.': [236]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2122265491', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 6}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 7}, {'year': 2014, 'cited_by_count': 8}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 11}], 'updated_date': '2024-12-10T08:40:32.597160', 'created_date': '2016-06-24'}